Chemoinformaics analysis of Methyl heptanoate
| Molecular Weight | 144.214 | nRot | 5 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 20 |
| Exact Molecular Weight | 144.115 | nRing | 0 |
| Solubility: LogS | -1.91 | nHRing | 0 |
| Solubility: LogP | 2.358 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.6327 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.929 |
| Synth | 3.939 |
| Natural Product Likeliness | 0.978 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.176 |
| Pgp-sub | 0.939 |
| HIA | 0.006 |
| CACO-2 | -4.653 |
| MDCK | 0.0000179 |
| BBB | 0.984 |
| PPB | 0.79728 |
| VDSS | 0.975 |
| FU | 0.132117 |
| CYP1A2-inh | 0.119 |
| CYP1A2-sub | 0.966 |
| CYP2c19-inh | 0.196 |
| CYP2c19-sub | 0.937 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.732 |
| CYP2d6-inh | 0.219 |
| CYP2d6-sub | 0.934 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.937 |
| CL | 13.074 |
| T12 | 0.749 |
| hERG | 0.077 |
| Ames | 0.18 |
| ROA | 0.303 |
| SkinSen | 0.342 |
| Carcinogencity | 0.038 |
| EI | 0.013 |
| Respiratory | 0.906 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.939148 |